KTC
CRL icon

Kistler-Tiffany Companies’s Charles River Laboratories CRL Stock Holding History

Kistler-Tiffany Companies’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$383K Buy
1,824
+252
+16% +$50.1K 0.06% 242
2023
Q1 		$317K Buy
1,572
+683
+77% +$155K 0.06% 239
2022
Q4 		$194K Buy
889
+799
+888% +$174K 0.04% 274
2022
Q3 		$18K Buy
+90
New +$19.4K ﹤0.01% 518

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Kistler-Tiffany Companies's CRL Position: Q2 2023 in Review

Kistler-Tiffany Companies increased its Charles River Laboratories (CRL) stake by 16% in Q2 2023, buying an estimated $50.1K and bringing the position to 1,824 shares worth $383K. The position accounts for 0.06% of the portfolio, ranked #242.

Kistler-Tiffany Companies first reported a position in CRL in Q3 2022 and has held it in 4 quarters since. 613 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Kistler-Tiffany Companies held 1,824 shares of Charles River Laboratories worth $383K as of Q2 2023.
  • Kistler-Tiffany Companies bought 252 Charles River Laboratories shares in Q2 2023, an estimated $50.1K.
  • Charles River Laboratories made up 0.06% of Kistler-Tiffany Companies's portfolio in Q2 2023, its #242 holding.
  • Kistler-Tiffany Companies first reported a position in Charles River Laboratories in Q3 2022 and has held it in 4 quarters since.
  • 613 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q2 2023, filed 1 Aug 2023.